Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Openly Rare with Paul Kidwell is a specialized media platform and podcast series focused on the rare disease community and the biopharmaceutical industry. Hosted by veteran communications consultant Paul Kidwell, the program provides a forum for patients, advocates, and industry executives to discuss the complexities of orphan drug development and patient care. The series aims to humanize the science behind rare disease treatments while addressing the unique regulatory and commercial challenges faced by biotech companies in this space. Through in-depth interviews, Openly Rare highlights the intersection of clinical innovation and patient advocacy. It serves as a strategic resource for stakeholders looking to understand the lived experience of rare diseases and the evolving landscape of the orphan drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Openly Rare with Paul Kidwell.